Commission Implementing Regulation (EU) 2024/859 of 18 March 2024 amending Regulation (EU) No 37/2010 as regards the classification of the substance sodium salicylate with respect to its maximum residue limit in foodstuffs of animal origin

• CELEX: Implementing Regulation (EU) 2024/859
• Articles: 3

Article 1

The Annex to Regulation (EU) No 37/2010 is amended as set out in the Annex to this Regulation.

Article 2

This Regulation shall enter into force on the twentieth day following that of its publication in the Official Journal of the European Union .

Schedules & Appendices

ANNEX

ANNEX

In Table 1 of the Annex to Regulation (EU) No 37/2010, the entry for the pharmacologically active substance ‘sodium salicylate’ is replaced by the following:

Pharmacologically active Substance

Marker residue

Animal Species

MRL

Target Tissues

Other Provisions

(according to Article 14(7) of Regulation (EC) No 470/2009)

Therapeutic Classification

‘Sodium salicylate

NOT APPLICABLE

Bovine, Porcine

No MRL required

NOT APPLICABLE

For oral use.

Not for use in animals from which milk is produced for human consumption.

NO ENTRY

All food producing species except fin fish

No MRL required

For topical use only.

Salicylic acid

Turkey

400 μg/kg

2 500 μg/kg

200 μg/kg

150 μg/kg

Muscle

Skin and fat in natural proportions

Liver

Kidney

Not for use in animals producing eggs for human consumption.

Anti-inflammatory agents / Non-steroidal anti-inflammatory agents’.

Poultry other than turkey

250 μg/kg

250 μg/kg

500 μg/kg

1 000 μg/kg

Muscle

Skin and fat in natural proportions

Liver

Kidney